Burleen Chhatwal from University College London, UK, will be presenting their work in neurological disorders research, implementing the latest technology of simultaneous sequencing of genetic and epigenetic bases. The presentation will demonstrate how biomodal’s 6-base genome supported the successful analysis of both 5mC and 5hmC modifications in Parkinson’s disease compared to controls in a pilot study.
- Webinar
Reveal the power of the 6-base genome and explore 5mC and 5hmC in Parkinson’s disease in the brain, with Burleen Chhatwal and Andrada Tomani
Burleen Chhatwal from University College London, UK, will be presenting their work in neurological disorders research, implementing the latest technology of simultaneous sequencing of genetic and epigenetic bases. The presentation will demonstrate how biomodal’s 6-base genome supported the successful analysis of both 5mC and 5hmC modifications in Parkinson’s disease compared to controls in a pilot study.
1:00 pm
to 1:20 pm
BST,
24 October 2024
- Webinar
Reveal the power of the 6-base genome and explore 5mC and 5hmC in Parkinson’s disease in the brain, with Burleen Chhatwal and Andrada Tomani
Burleen Chhatwal from University College London, UK, will be presenting their work in neurological disorders research, implementing the latest technology of simultaneous sequencing of genetic and epigenetic bases. The presentation will demonstrate how biomodal’s 6-base genome supported the successful analysis of both 5mC and 5hmC modifications in Parkinson’s disease compared to controls in a pilot study.
Originally presented on 24 October 2024.
